Manulife (Manufacturers Life Insurance)’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $559K | Buy |
494,500
+8,634
| +2% | +$9.76K | ﹤0.01% | 2125 |
|
|
2025
Q1 | $709K | Buy |
485,866
+1,151
| +0.2% | +$1.68K | ﹤0.01% | 1967 |
|
|
2024
Q4 | $1.03M | Sell |
484,715
-1,308
| -0.3% | -$2.79K | ﹤0.01% | 1895 |
|
|
2024
Q3 | $1.36M | Buy |
486,023
+5,642
| +1% | +$15.8K | ﹤0.01% | 1754 |
|
|
2024
Q2 | $1.12M | Buy |
480,381
+198,231
| +70% | +$462K | ﹤0.01% | 1798 |
|
|
2024
Q1 | $1.26M | Buy |
282,150
+76,916
| +37% | +$344K | ﹤0.01% | 1722 |
|
|
2023
Q4 | $659K | Buy |
205,234
+1,369
| +0.7% | +$4.39K | ﹤0.01% | 2042 |
|
|
2023
Q3 | $646K | Hold |
203,865
| – | – | ﹤0.01% | 2002 |
|
|
2023
Q2 | $1.01M | Buy |
203,865
+2,459
| +1% | +$12.2K | ﹤0.01% | 1656 |
|
|
2023
Q1 | $995K | Buy |
201,406
+25,492
| +14% | +$126K | ﹤0.01% | 1642 |
|
|
2022
Q4 | $1.06M | Buy |
175,914
+26,916
| +18% | +$162K | ﹤0.01% | 1577 |
|
|
2022
Q3 | $1.55M | Sell |
148,998
-647
| -0.4% | -$6.75K | ﹤0.01% | 1448 |
|
|
2022
Q2 | $1.74M | Buy |
149,645
+39,402
| +36% | +$458K | ﹤0.01% | 1448 |
|
|
2022
Q1 | $1.02M | Buy |
110,243
+73,504
| +200% | +$682K | ﹤0.01% | 1739 |
|
|
2021
Q4 | $548 | Sell |
36,739
-71
| -0.2% | -$1 | ﹤0.01% | 2202 |
|
|
2021
Q3 | $946K | Sell |
36,810
-2,808
| -7% | -$72.2K | ﹤0.01% | 1880 |
|
|
2021
Q2 | $1.03M | Buy |
39,618
+7,751
| +24% | +$202K | ﹤0.01% | 1975 |
|
|
2021
Q1 | $1.13M | Sell |
31,867
-1,795
| -5% | -$63.4K | ﹤0.01% | 1808 |
|
|
2020
Q4 | $850K | Buy |
33,662
+1,480
| +5% | +$37.4K | ﹤0.01% | 1910 |
|
|
2020
Q3 | $1.21M | Buy |
32,182
+1,792
| +6% | +$67.6K | ﹤0.01% | 1584 |
|
|
2020
Q2 | $1.27M | Buy |
30,390
+3,505
| +13% | +$147K | ﹤0.01% | 1529 |
|
|
2020
Q1 | $523K | Buy |
26,885
+1,435
| +6% | +$27.9K | ﹤0.01% | 1814 |
|
|
2019
Q4 | $661K | Sell |
25,450
-976
| -4% | -$25.3K | ﹤0.01% | 1891 |
|
|
2019
Q3 | $720K | Buy |
26,426
+427
| +2% | +$11.6K | ﹤0.01% | 1812 |
|
|
2019
Q2 | $698K | Buy |
25,999
+15,875
| +157% | +$426K | ﹤0.01% | 1844 |
|
|
2019
Q1 | $293K | Buy |
+10,124
| New | +$293K | ﹤0.01% | 2278 |
|